I am an independent Market Access Consultant, offering a focused, personalized, and impactful alternative to large consulting firms. Holding a PhD in Computational Chemistry from ETH Zurich, my 15-year career in the biotech industry encompasses product development, innovation, and commercial leadership. This unique blend of scientific rigor and business acumen provides a valuable asset for pharmaceutical and biotech companies navigating complex market access landscapes.

I serve as the Technology Officer for the HTAi (Health Technology Assessment international) Rare Disease Interest Group. In this role, I am at the forefront of discussions and initiatives aimed at improving patient access to innovative rare disease treatments within the international HTA framework.

My expertise spans across Europe, with a strong focus on the specific dynamics of the Swiss market. I specialize in developing and implementing strategic market access solutions for oncology, rare disease products, and beyond.

Unlike larger consultancies, I offer a direct, hands-on approach, ensuring your specific needs are met with tailored and effective strategies. I am available for a range of engagements, including interim support, project-based collaborations, and deliverable-based assignments.

My core expertise includes:

• Swiss Market Access & Reimbursement: Navigating the complexities of Swiss pricing and reimbursement (P&R) dossier submissions to BAG, with a strong understanding of local reimbursement laws and market dynamics.
• Oncology & Rare Disease Expertise: Possessing a deep understanding of the unique challenges and opportunities within the oncology and rare disease markets, including competitive landscapes and regulatory requirements.
• Market Access Strategy & Pricing: Developing robust global market access strategies, value-based pricing scenarios, and effective reimbursement strategies for European markets, with a particular focus on Switzerland.
• Health Economics & Data Analysis: Leveraging strong analytical skills in market intelligence, payer research, and revenue forecasting to support strategic decision-making.
• Stakeholder Engagement & Communication: Building and maintaining strong relationships with key stakeholders, coupled with excellent communication and presentation abilities, particularly within the HTA and policy environment.
• Regulatory Understanding: Effectively bridging the gap between regulatory marketing authorization and market access requirements.